title: Satisfaction with treatment among patients with psoriasis: a web-based survey study.
abstract: BACKGROUND
  Various psoriasis treatments are currently available: topical therapy, photo(chemo)therapy, oral agents and biologics. Little is known about patients' satisfaction with these treatment options. Moreover, the few available studies show methodological shortcomings.
  
  
  OBJECTIVE
  To answer the following questions: firstly, how satisfied are patients with psoriasis with their current treatment and does patients' satisfaction significantly differ between treatment types when controlling for demographic and clinical factors? Secondly, how important are specific domains of satisfaction to patients, and when taking perceived importance into account, which domains merit the most attention in improving quality of care?
  
  
  METHODS
  Members of the two existing Dutch associations for patients with psoriasis were invited to complete a web-based survey, which included a study-specific satisfaction questionnaire.
  
  
  RESULTS
  A total of 1293 patients completed the survey (response rate 32%). Overall, patients were moderately satisfied with their current treatment. Patients receiving topical treatment were significantly least satisfied; patients receiving biologic treatment were significantly most satisfied. Overall, patients rated 'treatment effectiveness' as most important, followed by 'treatment safety' and 'doctor-patient communication'. Domains with the highest 'room for improvement' scores were effectiveness of topical therapy, phototherapy and oral agents (but not biologic treatment), convenience of topical treatment and safety of systemic treatments (both oral agents and biologics).
  
  
  CONCLUSIONS
  From the perspective of patients, biologic treatment is promising. To improve further the quality of psoriasis care, the effectiveness and convenience of topical therapies, the safety of systemic therapies, and doctors' communication skills need to be addressed.
authors.affiliation: Department of Dermatology, University of Amsterdam, AZ Amsterdam, The Netherlands. o.d.vancranenburgh@amc.uva.nl
authors.forename: O D
authors.initials: OD
authors.lastname: van Cranenburgh
authors.forename: J
authors.initials: J
authors.lastname: de Korte
authors.forename: M A G
authors.initials: MA
authors.lastname: Sprangers
authors.forename: M A
authors.initials: MA
authors.lastname: de Rie
authors.forename: E M A
authors.initials: EM
authors.lastname: Smets
mesh_terms: D000279:Administration, Cutaneous; D000284:Administration, Oral; D001685:Biological Factors / Q000008:administration & dosage; D003142:Communication; D003430:Cross-Sectional Studies; D003879:Dermatologic Agents / Q000008:administration & dosage; D005260:Female; D006306:Health Surveys; D006801:Humans; D020407:Internet; D008297:Male; D008875:Middle Aged; D010353:Patient Education as Topic; D017060:Patient Satisfaction; D010789:Phototherapy / Q000523:psychology; D010817:Physician-Patient Relations; D011565:Psoriasis / Q000523:psychology / Q000628:therapy*; D016896:Treatment Outcome
chemical_list: D001685:Biological Factors; D003879:Dermatologic Agents